Search
for
Sort by
Research 691–720 of 1000+
- 575 An extract of Leontopodium alpinum prolongs anagen phase in human hair follicles ex vivo
- Genetic Defects of Female Sexual Differentiation
- British Society for Dermatopathology
- Classified Advertising
- Classified Advertising
- 17927 A pilot study of intrascalp platelet-rich plasma injections for hair loss in Nigerian patients
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Monoterpenoid Loliolide Regulates Hair Follicle Inductivity of Human Dermal Papilla Cells by Activating the Akt/ ¥-Catenin Signaling Pathway
- Ginsenoside Rg4 Enhances the Inductive Effects of Human Dermal Papilla Spheres on Hair Growth Via the AKT/GSK-3β/β-Catenin Signaling Pathway
- Flavonoid Silibinin Increases Hair-Inductive Property Via Akt and Wnt/��-Catenin Signaling Activation in 3-Dimensional-Spheroid Cultured Human Dermal Papilla Cells
- PROTACs: A novel strategy for cancer drug discovery and development
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- JAK inhibitors in dermatology: The promise of a new drug class
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Multi-omics and AI-driven advances in miRNA-mediated hair follicle regulation in cashmere goats
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- A phase 2a trial of brepocitinib for cicatricial alopecia
- JAK Inhibitors for Treatment of Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Case-Only Trees and Random Forests for Exploring Genotype-Specific Treatment Effects in Randomized Clinical Trials with Dichotomous End Points